Boston Scientific BSX
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 1st percentile, 5-year average 66.3x
#1401 of 2972 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 0th percentile, 5-year average 4.7x
#3368 of 5311 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 0th percentile, 5-year average 6.2x
#3055 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 2.44 | – | 4.70 | 0% (cheaper than usual) | #3368 of 5311 (1 = cheapest) |
| PE | 17.71 | 20.29 | 66.34 | 1% (cheaper than usual) | #1401 of 2972 (1 = cheapest) |
| PS | 2.89 | 2.95 | 6.17 | 0% (cheaper than usual) | #3055 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on BSX.
Sign in to join the discussion.